IL17A and neoplasm: T-helper 1 (Th1) and T-helper 2 (Th2) cells induced in the TME by proinflammatory cytokines enhance TIL antitumor activity, while the role of Th17 cells remains poorly understood but likely promotes tumor growth depending on the role of interleukin-17 (IL-17).